Stephan A. Grupp - Concepedia

Author

Stephan A. Grupp

Children's Hospital of Philadelphia ORCID

Also Known As

David Barrett, Grupp, Stephan A., S A Grupp, S Grupp, S. A. Grupp, S. Grupp, S.A. Grupp, STEPHAN A. GRUPP, Stephan A Grupp, Stephan A. Grupp

801

Publications

61.6K

Citations

103

H-Index

149

Concepts

All Affiliations

Children's Hospital of Philadelphia University of Pennsylvania Children's Hospital of Los Angeles Dana-Farber Cancer Institute University of Michigan

About

Stephan A. Grupp is an author at Children's Hospital of Philadelphia specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	80	11K
2	Health Sciences	17	20	1.4K
3	Blood Transplantation	6	6	215
4	Allergy	4	4	446
5	Engineering	1	1	119

Stephan A. Grupp

242

Publications

51.3K

Citations

H-Index

Page 1

	Year	Citations
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, New England Journal of Medicine	2018	5.4K
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw, New England Journal of Medicine	2014	5.3K
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia Stephan A. Grupp, Michael Kalos, David M. Barrett, New England Journal of Medicine T-regulatory CellImmune RegulationImmunologyImmunodominanceCd4 T Cell Responses	2013	3.4K
Current concepts in the diagnosis and management of cytokine release syndrome Daniel W. Lee, Rebecca Gardner, David Porter, Blood	2014	2.7K
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia Michael Kalos, Bruce L. Levine, David L. Porter, Science Translational Medicine	2011	2.4K
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak, New England Journal of Medicine	2010	1.8K
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia Haydar Frangoul, David Altshuler, Maria Domenica Cappellini, New England Journal of Medicine	2020	1.7K
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia David Porter, Wei‐Ting Hwang, Noelle V. Frey, Science Translational Medicine	2015	1.7K
Convergence of Acquired Mutations and Alternative Splicing of <i>CD19</i> Enables Resistance to CART-19 Immunotherapy Elena Sotillo, David M. Barrett, Kathryn L. Black, Cancer Discovery	2015	1.2K
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo Michael C. Milone, Jonathan D. Fish, Carmine Carpenito, Molecular Therapy	2009	1.2K

Page 1